Researchers from the University of Colorado Cancer Center have solved a cellular mystery that may lead to better therapies ...

Aprea Therapeutics, Inc. (Nasdaq: APRE) ("Aprea”, or the "Company”), a clinical-stage biopharmaceutical company developing innovative treatments that exploit specific cancer cell vulnerabilities while ...

The death of former U.S. Rep. Mia Love has brought renewed attention to an aggressive form of brain cancer that killed her at ...

B-cell acute lymphoblastic leukemia (B-ALL) is a life-threatening and highly aggressive form of blood cancer. It is the most common childhood cancer, making up 35% of pediatric cancer cases, but it ...

SAN DIEGO and SUZHOU, China, March 24, 2025 (GLOBE NEWSWIRE) -- Adagene Inc. ("Adagene”) (Nasdaq: ADAG), a platform-driven, clinical-stage biotechnology company transforming the discovery and ...

What drew you to pursue a career in oncology and what is it that inspires you most about working in this field?

The method triggers immune responses that inhibit melanoma, triple-negative breast cancer, lung carcinoma, and ovarian cancer ...

Treatment of B-cell Acute Lymphoblastic Leukaemia has been greatly improved by CAR-T therapies, but relapse is still very common. An international team has now found in animal models a new approach ...

Although cystic fibrosis is a single gene mutation, there are more than 1,000 different ways the CFTR gene can mutate in ...

Successful treatment of mucinous adenocarcinoma with HIPEC at Be Well Hospitals by expert surgeons led by Dr. Sabarisan.

Most cells in the body send out little messengers called extracellular vesicles that carry proteins, lipids, and other ...

Colorectal cancer, also known as bowel cancer, colon cancer, or rectal cancer, refers to any cancer that affects the colon and rectum. Common signs of colorectal cancer include blood in the stool ...